TARS – tarsus pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Tarsus Pharmaceuticals (TARS) was downgraded by Wall Street Zen from
Tarsus Pharmaceuticals (TARS) was downgraded by Zacks Research from "strong-buy" to "hold".
Tarsus to Participate in Upcoming Investor Conferences
Has The Market Rerated Tarsus Pharmaceuticals (TARS) Too Cautiously After XDEMVY Adoption Headlines? [Yahoo! Finance]
Tarsus Pharmaceuticals (TARS) had its price target raised by Oppenheimer Holdings, Inc. from $95.00 to $105.00. They now have an "outperform" rating on the stock.
Form 4 Tarsus Pharmaceuticals, For: Mar 04 Filed by: Neervannan Seshadri
Form 144 Tarsus Pharmaceuticals, Filed by: Neervannan Seshadri
Form S-8 Tarsus Pharmaceuticals,
Form 10-K Tarsus Pharmaceuticals, For: Dec 31
Form 8-K Tarsus Pharmaceuticals, For: Feb 23
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.